vs
FLANIGANS ENTERPRISES INC（BDL）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
FLANIGANS ENTERPRISES INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.5倍（$52.6M vs $35.5M），FLANIGANS ENTERPRISES INC净利率更高（1.5% vs -304.2%，领先305.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 4.6%），FLANIGANS ENTERPRISES INC自由现金流更多（$4.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 4.6%）
Flanigans Enterprises Inc.是一家总部位于美国的餐饮服务企业，主要在佛罗里达州开展业务，旗下拥有Flanigan's海鲜酒吧烧烤连锁休闲餐厅及零售酒类门店，服务客群覆盖当地居民与区域游客，提供平价海鲜、美式家常餐食及各类饮品。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BDL vs RXRX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.6M | $35.5M |
| 净利润 | $805.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 3.2% | -304.8% |
| 净利率 | 1.5% | -304.2% |
| 营收同比 | 4.6% | 681.7% |
| 净利润同比 | 1363.6% | 39.6% |
| 每股收益（稀释后） | $0.43 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $52.6M | $35.5M | ||
| Q3 25 | $50.0M | $5.2M | ||
| Q2 25 | $51.9M | $19.2M | ||
| Q1 25 | $53.4M | $14.7M | ||
| Q4 24 | $50.0M | $4.5M | ||
| Q3 24 | $45.4M | $26.1M | ||
| Q2 24 | $48.8M | $14.4M | ||
| Q1 24 | $48.1M | $13.8M |
| Q4 25 | $805.0K | $-108.1M | ||
| Q3 25 | $896.0K | $-162.3M | ||
| Q2 25 | $1.4M | $-171.9M | ||
| Q1 25 | $2.7M | $-202.5M | ||
| Q4 24 | $55.0K | $-178.9M | ||
| Q3 24 | $184.0K | $-95.8M | ||
| Q2 24 | $1.1M | $-97.5M | ||
| Q1 24 | $1.9M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 3.2% | -304.8% | ||
| Q3 25 | 3.3% | -3327.6% | ||
| Q2 25 | 5.5% | -916.8% | ||
| Q1 25 | 6.6% | -1297.9% | ||
| Q4 24 | 1.5% | -4042.4% | ||
| Q3 24 | 0.7% | -377.1% | ||
| Q2 24 | 4.4% | -697.4% | ||
| Q1 24 | 5.6% | -698.4% |
| Q4 25 | 1.5% | -304.2% | ||
| Q3 25 | 1.8% | -3135.3% | ||
| Q2 25 | 2.7% | -894.2% | ||
| Q1 25 | 5.0% | -1373.3% | ||
| Q4 24 | 0.1% | -3935.5% | ||
| Q3 24 | 0.4% | -367.5% | ||
| Q2 24 | 2.3% | -676.6% | ||
| Q1 24 | 4.0% | -662.4% |
| Q4 25 | $0.43 | $-0.17 | ||
| Q3 25 | $0.48 | $-0.36 | ||
| Q2 25 | $0.75 | $-0.41 | ||
| Q1 25 | $1.45 | $-0.50 | ||
| Q4 24 | $0.03 | $-0.56 | ||
| Q3 24 | $0.11 | $-0.34 | ||
| Q2 24 | $0.60 | $-0.40 | ||
| Q1 24 | $1.04 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $66.0M | $1.1B |
| 总资产 | $142.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | $732.0K | $525.1M | ||
| Q1 25 | $244.0K | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $20.9M | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $22.2M | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $66.0M | $1.1B | ||
| Q3 25 | $65.2M | $1.0B | ||
| Q2 25 | $64.3M | $919.1M | ||
| Q1 25 | $64.0M | $933.9M | ||
| Q4 24 | $61.6M | $1.0B | ||
| Q3 24 | $61.2M | $524.6M | ||
| Q2 24 | $61.3M | $584.4M | ||
| Q1 24 | $61.1M | $401.2M |
| Q4 25 | $142.1M | $1.5B | ||
| Q3 25 | $140.6M | $1.4B | ||
| Q2 25 | $140.7M | $1.3B | ||
| Q1 25 | $143.3M | $1.3B | ||
| Q4 24 | $146.9M | $1.4B | ||
| Q3 24 | $142.1M | $726.5M | ||
| Q2 24 | $143.1M | $775.9M | ||
| Q1 24 | $144.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.32× | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.36× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $4.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 8.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 6.14× | — |
| 过去12个月自由现金流最近4个季度 | $2.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $4.9M | $-46.1M | ||
| Q3 25 | $3.4M | $-117.4M | ||
| Q2 25 | $1.4M | $-76.4M | ||
| Q1 25 | $-2.0M | $-132.0M | ||
| Q4 24 | $7.7M | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | $3.1M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
| Q4 25 | $4.5M | $-47.3M | ||
| Q3 25 | $2.4M | $-117.6M | ||
| Q2 25 | $-1.8M | $-79.6M | ||
| Q1 25 | $-3.0M | $-133.8M | ||
| Q4 24 | $7.0M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | $2.2M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | 8.5% | -133.1% | ||
| Q3 25 | 4.9% | -2272.5% | ||
| Q2 25 | -3.4% | -413.9% | ||
| Q1 25 | -5.5% | -907.4% | ||
| Q4 24 | 13.9% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | 4.5% | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | 0.9% | 3.5% | ||
| Q3 25 | 1.9% | 4.7% | ||
| Q2 25 | 6.1% | 16.4% | ||
| Q1 25 | 1.8% | 12.4% | ||
| Q4 24 | 1.5% | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | 1.8% | 8.2% | ||
| Q1 24 | — | 48.2% |
| Q4 25 | 6.14× | — | ||
| Q3 25 | 3.75× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 140.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.75× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BDL
| Restaurant Food Sales | $30.9M | 59% |
| Package Store Sales | $13.3M | 25% |
| Restaurant Bar Sales | $7.9M | 15% |
RXRX
暂无分部数据
